These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2798938)

  • 41. Cellular Response to Exponentially Increasing and Decreasing Dose Rates: Implications for Treatment Planning in Targeted Radionuclide Therapy.
    Solanki JH; Tritt T; Pasternack JB; Kim JJ; Leung CN; Domogauer JD; Colangelo NW; Narra VR; Howell RW
    Radiat Res; 2017 Aug; 188(2):221-234. PubMed ID: 28541775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy.
    Guerrero M; Li XA
    Phys Med Biol; 2004 Oct; 49(20):4825-35. PubMed ID: 15566178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Normal tissue complication probability modelling of tissue fibrosis following breast radiotherapy.
    Alexander MA; Brooks WA; Blake SW
    Phys Med Biol; 2007 Apr; 52(7):1831-43. PubMed ID: 17374914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How low is the alpha/beta ratio for prostate cancer?
    Wang JZ; Guerrero M; Li XA
    Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):194-203. PubMed ID: 12504054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A LQ-based kinetic model formulation for exploring dynamics of treatment response of tumours in patients.
    Scheidegger S; Lutters G; Bodis S
    Z Med Phys; 2011 Sep; 21(3):164-73. PubMed ID: 21237624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dose painting and theragnostic imaging: towards the prescription, planning and delivery of biologically targeted dose distributions in external beam radiation oncology.
    Bentzen SM
    Cancer Treat Res; 2008; 139():41-62. PubMed ID: 18236711
    [No Abstract]   [Full Text] [Related]  

  • 47. A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy.
    Wang JZ; Huang Z; Lo SS; Yuh WT; Mayr NA
    Sci Transl Med; 2010 Jul; 2(39):39ra48. PubMed ID: 20610850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statistical methods for clinical verification of dose-response parameters related to esophageal stricture and AVM obliteration from radiotherapy.
    Mavroidis P; Lind BK; Theodorou K; Laurell G; Fernberg JO; Lefkopoulos D; Kappas C; Brahme A
    Phys Med Biol; 2004 Aug; 49(16):3797-816. PubMed ID: 15446806
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radiation treatment outcomes for unresectable hepatocellular carcinoma.
    Skinner HD; Sharp HJ; Kaseb AO; Javle MM; Vauthey JN; Abdalla EK; Delclos ME; Das P; Crane CH; Krishnan S
    Acta Oncol; 2011 Nov; 50(8):1191-8. PubMed ID: 21793641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative assessment of radiation dose and fractionation effects on normal tissue by utilizing a novel lung fibrosis index model.
    Zhou C; Jones B; Moustafa M; Schwager C; Bauer J; Yang B; Cao L; Jia M; Mairani A; Chen M; Chen L; Debus J; Abdollahi A
    Radiat Oncol; 2017 Nov; 12(1):172. PubMed ID: 29116014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiation-induced lung damage: dose-time fractionation considerations.
    Fowler JF
    Radiother Oncol; 1990 Jun; 18(2):184-7. PubMed ID: 2367693
    [No Abstract]   [Full Text] [Related]  

  • 52. Prediction of normal tissue response and individualization of doses in radiotherapy.
    Guirado D; Ruiz de Almodóvar JM
    Phys Med Biol; 2003 Oct; 48(19):3213-23. PubMed ID: 14579861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.
    Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Equivalence of the linear-quadratic and two-lesion kinetic models.
    Guerrero M; Stewart RD; Wang JZ; Li XA
    Phys Med Biol; 2002 Sep; 47(17):3197-209. PubMed ID: 12361218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of the rate of expression of radiation-induced renal damage and the effects of hyperfractionation.
    Lebesque JV; Stewart FA; Hart AA
    Radiother Oncol; 1986 Feb; 5(2):147-57. PubMed ID: 3704189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Normal tissue responses to radiation therapy.
    Bloomer WD; Hellman S
    N Engl J Med; 1975 Jul; 293(2):80-3. PubMed ID: 1093032
    [No Abstract]   [Full Text] [Related]  

  • 57. Biologically effective dose using reciprocal repair for varying fraction doses and fraction intervals.
    Buckle AH; Lewis J
    Br J Radiol; 2008 Feb; 81(962):137-42. PubMed ID: 18070828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategy for stochastic dose-rate induced enhanced elimination of malignant tumour without dose escalation.
    Paul S; Roy PK
    Math Med Biol; 2016 Sep; 33(3):319-28. PubMed ID: 26049156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of late effects data using dose-response models: application to human skin telangiectasia data.
    Baltas D; Fehrentz D; Turesson I
    Radiother Oncol; 1989 Sep; 16(1):41-53. PubMed ID: 2813836
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical evaluation of radiation complications with various methods of radiotherapy for vaginal cancer].
    Kanaev SV; Turkevich VG
    Vopr Onkol; 1997; 43(2):183-7. PubMed ID: 9214119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.